Roche Italy Roche.com Contact us Site map Text size Home Roche in Italy Social responsability Personalized Medicine R&D Average Working at Roche Roche in Italy Pharmaceuticals Virology and AIDS Virology and AIDS The flu is a real danger to our immune system Influenza viruses attack the immune systems of over 100 million people every year in Europe, Japan and the United States alone; moreover, there are up to 500,000 deaths per year associated with these pathologies worldwide. Since their profile changes slightly every year, particularly "fragile" subjects from an immune point of view can develop infections, even serious ones, which need to be addressed with due importance. Early detection of hepatitis increases the chances of recovery Chronic hepatitis is a viral infection that remains active in the body even for years. If not treated, it can lead to chronic disabling forms linked to the onset of phenomena such as cirrhosis and liver failure, as well as favoring the development of tumors. Specifically, chronic HCV infection, better known as hepatitis C, represents a "silent epidemic" as it can be asymptomatic for a long time. There are 3 to 4 million new cases every year around the world. In such a context, it becomes extremely important to identify and treat the disease in the early stages, when the chances of recovery are relatively high. Thanks to tests for the diagnosis and monitoring of the virus in the blood and drugs developed by various pharmaceutical companies including Roche, millions of people who have been successfully treated have managed to eradicate the HCV virus from their bodies. Roche's R&D efforts have allowed us to develop effective therapeutic strategies also in the treatment of chronic HBV hepatitis, better known as hepatitis B. HIV / AIDS Il virus HIV, responsabile delle forme cliniche conosciute e descritte come AIDS, è un virus non ancora eradicabile dall'organismo. Fortunatamente in questi anni si sta registrando una forte riduzione del numero di casi di decesso. Ciò è dovuto principalmente alla moderna diagnostica molecolare, grazie alla quale è possibile individuare e monitorare in modo rapido e affidabile non solo il virus in sé, ma anche la sua resistenza, modificando di conseguenza la terapia cui sottoporre i pazienti. La Ricerca e Sviluppo di Roche ha messo a disposizione della Comunità Scientifica la prima molecola inibitrice della proteasi virale, favorendo quella rivoluzione terapeutica che è stata la combinazione terapeutica ad alta efficacia (HAART), combinazione che ha consentito la "cronicizzazione" dell'infezione stessa. Roche ha anche sviluppato il primo inibitore della fusione di HIV con la cellula ospite, farmaco antesignano di una nuova opzione terapeutica tesa a limitare l'aggressione da parte del virus HIV del sistema immunitario del soggetto infetto. Queste due molecole hanno rappresentato sicuramente un approccio innovativo alla terapia specifica per l'infezione da HIV, con numerose ricadute positive sulla sopravvivenza e sulla qualità di vita dei pazienti. Come back upstairs HIV / AIDS Definition Of HIV / AIDS Definition of HIV / AIDS 01:59 Causes Causes 03:39 Preparations Preparations 02:45 Diagnosis Diagnosis 00:49 Therapy Therapy 02:18 Prevention Prevention 00:46 Hepatitis Definition Of Hepatitis Definition of Hepatitis 02:34 Causes Causes 02:19 Preparations Preparations 02:22 Diagnosis Diagnosis 01:45 Therapy Therapy 02:18 Prevention Prevention 1 o'clock Influence Definition Of Influence Definition of Influence 00:51 Causes Causes 00:53 Preparations Preparations 02:18 Diagnosis Diagnosis 01:05 Therapy Therapy 1 o'clock Prevention Prevention 01:06 “Viral diseases represent a serious and insidious health risk. Viruses are often not detected in time and consequently replicate in the body in an uncontrolled way. Viruses pathogenic for humans also tend to evade the normal immune defenses of the host, resulting in a more difficult mechanism for controlling the viral pathology itself. " Print add to favourites Virology and AIDS The flu is a real danger to our immune system Early detection of hepatitis increases the chances of recovery HIV / AIDS Pharmaceuticals Oncology Virology Metabolism disorders Rheumatology Central nervous system Anemia and transplants Privacy disclaimer Terms and conditions Cookie information © Copyright 2014 Roche SpA - single-member company - VAT number 00747170157 14.09.2015 X This website uses cookie technology. For more information or to refuse consent to the installation of cookies, consult ours information on cookies. By closing this notification or continuing to browse, you consent to the use of cookies. Accept